2022-11-10T10:46:03-06:00 2021-12-31 521446779 JOHNSON LAMBERT LLP 4242 SIX FORKS ROAD SUITE 1500 RALEIGH NC 27609 990 2021-01-01 030466352 THE GOG FOUNDATION INC GOGF 4107217126 3168 BRAVERTON ST 280 EDGEWATER MD 21037 MARY C SHARP CHIEF FINANCIAL OFFICER 4107217126 2022-11-09 1 MARY SHARP XXX-XX-XXXX J CALVIN MARKS P01226973 9197196400 3 AAL1 IAL1 2021 2022-09-23 18:48:47Z LARRY J COPELAND MD 3168 BRAVERTON ST 280 EDGEWATER MD 21037 88596486 0 X WWW.GOG.ORG X 2002 DC THE GOG FOUNDATION'S PRIMARY EXEMPT PURPOSE IS TO PROMOTE EXCELLENCE IN THE QUALITY AND INTEGRITY OF CLINICAL AND BASIC SCIENTIFIC RESEARCH IN THE FIELD OF GYNECOLOGIC MALIGNANCIES. 11 9 49 10 30841 17268 3264417 2532775 44774881 62113804 3089564 6285565 4954 139537 51133816 71071681 543825 240000 0 0 5860539 7098442 0 0 367774 43957850 53320348 50362214 60658790 771602 10412891 101233590 118907888 24744008 28813492 76489582 90094396 X THE GOG FOUNDATION, INC. (GOG FOUNDATION) IS A NONPROFIT ORGANIZATION WITH THE PURPOSE OF PROMOTING EXCELLENCE IN THE QUALITY AND INTEGRITY OF CLINICAL AND BASIC SCIENTIFIC RESEARCH IN THE FIELD OF GYNECOLOGIC MALIGNANCIES, INCLUDING CANCERS THAT ARISE FROM THE OVARIES, UTERUS, CERVIX, VAGINA, AND VULVA. OUR INSTITUTIONS AND INVESTIGATORS ARE ESSENTIAL CONTRIBUTORS TO ADVANCEMENTS IN TREATMENT REGIMENS, SURGICAL PROCEDURES, QUALITY OF LIFE ANALYSES, AND PREVENTION KNOWLEDGE. THE RESULTS OF GOG FOUNDATION CLINICAL TRIALS HAVE INFLUENCED THE STANDARD OF CARE FOR NUMEROUS MALIGNANT GYNECOLOGIC NEOPLASMS. THE MISSION OF THE GOG FOUNDATION IS TO CONDUCT CLINICAL AND TRANSLATIONAL RESEARCH THAT POSITIVELY IMPACTS WOMEN THROUGH THE PREVENTION AND TREATMENT OF GYNECOLOGIC MALIGNANCIES. THE VISION OF THE GOG FOUNDATION IS TO BE THE PREMIER COLLABORATIVE NETWORK FOR TRANSFORMATIVE RESEARCH IN GYNECOLOGIC MALIGNANCIES. 0 0 60531016 240000 62113804 THE FOUNDATION IS COMMITTED TO MAINTAINING THE HIGHEST STANDARDS IN CLINICAL TRIALS DEVELOPMENT, EXECUTION, ANALYSIS AND DISTRIBUTION OF RESULTS. CONTINUOUS EVALUATION OF OUR PROCESSES IS UTILIZED IN ORDER TO CONSTANTLY IMPROVE THE QUALITY OF PATIENT CARE. IN 2021 THE GOG FOUNDATION, INC. CONDUCTED CLINICAL TRIALS THROUGH OUR 300 PLUS INSTITUTIONS. THESE EXPENSES INCLUDED PROTOCOL DEVELOPMENT, REGULATORY AFFAIRS, MEETINGS TO REVIEW TRIAL DATA, TRIAL DEVELOPMENT THROUGH COMMITTEE FUNCTIONS AND OTHER INDIRECT RELATED EXPENSES. 60531016 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 91 0 1 49 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 11 9 0 0 1 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 MD X MARY C SHARP CFO 4107217126 3168 BRAVERTON ST NO 280 EDGEWATER MD 21037 X MARY SHARP CHIEF FINANCIAL OFFICER 35.00 X 297711 0 62769 MICHAEL S POWERS GENERAL COUNSEL 35.00 X 283474 0 44285 LAURE L REESE EXECUTIVE DIRECTOR 35.00 X 265440 0 60253 JENNIFER T KIEN DIR, COMMUNICATIONS 35.00 X 221464 0 62036 KATHLEEN E CAMPBELL-SIMMS DIR, SITE MANAGEMENT 35.00 X 164892 0 55379 LISA M RICHFORD CONTRACTS ATTORNEY 35.00 X 145730 0 62454 HEATHER LANKES DIR, TRANSLATIONAL SCIENCE 35.00 X 162172 0 42973 JOSH J KILLION DIR, IT 35.00 X 167502 0 33936 NOLA R BENCZE COMPLIANCE ATTORNEY 35.00 X 154631 0 44454 DENISE R MACKEY DIR, ADMINISTRATION 35.00 X 154572 0 43312 LARRY J COPELAND MD PRESIDENT 20.00 X X 100000 0 0 ROBERT S MANNEL MD SR. VICE PRESIDENT 13.00 X X 33333 0 0 THOMAS J HERZOG MD TREASURER 1.00 X X 0 0 0 DAVID G MUTCH MD SECRETARY 1.00 X X 0 0 0 ROBERT L COLEMAN MD DIRECTOR-AT-LARGE 1.00 X 0 0 0 PAUL A DISILVESTRO MD DIRECTOR-AT-LARGE 1.00 X 0 0 0 BRADLEY J MONK MD DIRECTOR-AT-LARGE 1.00 X 0 0 0 KATHLEEN N MOORE MD DIRECTOR-AT-LARGE 1.00 X 0 0 0 ALEXANDER B OLAWAIYE MD DIRECTOR-AT-LARGE 1.00 X 0 0 0 ANGELES ALVAREZ SECORD MD DIRECTOR-AT-LARGE 1.00 X 0 0 0 LESLIE M RANDALL MD DIRECTOR-AT-LARGE 1.00 X 0 0 0 2150921 0 511851 18 0 1 0 UNIVERSITY CANCER AND BLOOD CENTER 3320 OLD JEFFERSON RD BLDG 700 ATHENS GA 30607 CONSULTING SERVICES 203175 DR ROBERT COLEMAN MD 9180 PINECROFT DR STE 600 THE WOODLANDS TX 77380 CONSULTING SERVICES 199875 DR LARRY J COPELAND MD 320 W 10TH AVE COLUMBUS OH 43210 CONSULTING SERVICES 166400 BIG FLY CONSULTING 2000 ASHBURTON WAY MOUNT PLEASANT SC 29466 CONSULTING SERVICES 124900 4 2313946 218829 2532775 INDUSTRY REVENUE 900099 62101629 62101629 REGISTRATION FEES 900099 12175 12175 62113804 2353060 30841 2322219 21457310 17524805 3932505 3932505 3932505 139537 139537 139537 71071681 62113804 30841 6394261 240000 240000 1521161 854144 602008 65009 3986971 2171798 1654387 160786 615465 360887 227754 26824 610511 323918 217219 69374 364334 201572 143785 18977 478990 478990 149839 149839 1144721 796821 347900 794 794 172657 91056 81601 196655 4616 189899 2140 440567 272853 167714 35299 34891 408 264690 231162 33528 332940 332940 PURCHASE SERVICE AGREEM 45825596 45825596 CONSORTIUMS 3033833 3033833 HONORARIA 735953 735953 OVERHEAD ALLOCATION 0 4751203 -4751203 507814 121723 361427 24664 60658790 60531016 -240000 367774 4461 961 18554894 24705221 755334 388266 4418832 5504189 103709 43068 68885379 81762688 7654141 5466267 802251 985449 54589 51779 101233590 118907888 5450476 9120248 19293532 19693244 24744008 28813492 X 76489582 90094396 76489582 90094396 101233590 118907888 10412891 3191923 0 X 0 1 X 1 1 1 X 5135505 3475111 2990743 3264417 2532775 17398551 5135505 3475111 2990743 3264417 2532775 17398551 17398551 1486285 1558710 2026706 2080100 2322219 9474020 37116 115076 21845 18803 192840 23997 48680 4954 139537 217168 27282579 194657966 0.63770 0.69960 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 X 74263604 3191923 3191923 71071681 0 71071681 60658790 0 60658790 0 60658790 PART X, LINE 2: MANAGEMENT HAS CONCLUDED THAT GOG FOUNDATION HAS PROPERLY MAINTAINED ITS EXEMPT STATUS, AND THERE ARE NO UNCERTAIN TAX POSITIONS AS OF DECEMBER 31, 2021 OR 2020. CENTRAL AMERICA AND THE CARIBBEAN 0 0 INVESTMENTS 2487000 0 0 0 0 0 0 2487000 0 2487000 0 0 1 0 1 0 PART III ACCOUNTING METHOD: 1 CURATORS OF THE UNIVERSITY OF MISSOURI SPECIAL TR 407 REYNOLDS ALUMNI CTR COLUMBIA MO 65211 266440629 501(C)(3) 150000 0 GENERAL PURPOSE GRANT SOCIETY OF GYNECOLOGIC ONCOLOGY 230 W MONROE ST STE 710 CHICAGO IL 60606 611657046 501(C)(6) 50000 0 SGO FLY IN DAY NRG ONCOLOGY FOUNDATION INC 1600 JFK BLVD STE 1020 PHILADELPHIA PA 19103 900912747 501(C)(3) 40000 0 URM AWARD 2 1 PART I, LINE 2: THE GOG FOUNDATION SELECTS ORGANIZATIONS FOR GRANTS THAT FURTHER THE EXEMPT PURPOSE OF THE GOG FOUNDATION. THE RECIPIENTS OF THESE GRANTS ARE EXEMPT ORGANIZATIONS WITH MISSIONS CONGRUOUS WITH THOSE OF THE GOG FOUNDATION. X X 0 0 0 0 0 0 0 0 0 MARY SHARP CHIEF FINANCIAL OFFICER 279147 0 10375 0 8189 0 45095 0 17674 0 360480 0 0 0 MICHAEL S POWERS GENERAL COUNSEL 265360 0 10375 0 7739 0 42618 0 1667 0 327759 0 0 0 LAURE L REESE EXECUTIVE DIRECTOR 247760 0 10375 0 7305 0 40230 0 20023 0 325693 0 0 0 JENNIFER T KIEN DIR, COMMUNICATIONS 204524 0 10375 0 6565 0 33809 0 28227 0 283500 0 0 0 KATHLEEN E CAMPBELL-SIMMS DIR, SITE MANAGEMENT 148517 0 9875 0 6500 0 25350 0 30029 0 220271 0 0 0 LISA M RICHFORD CONTRACTS ATTORNEY 129550 0 10375 0 5805 0 22638 0 39816 0 208184 0 0 0 HEATHER LANKES DIR, TRANSLATIONAL SCIENCE 145463 0 10375 0 6334 0 24702 0 18271 0 205145 0 0 0 JOSH J KILLION DIR, IT 150620 0 10375 0 6507 0 25378 0 8558 0 201438 0 0 0 NOLA R BENCZE COMPLIANCE ATTORNEY 138752 0 9750 0 6129 0 23903 0 20551 0 199085 0 0 0 DENISE R MACKEY DIR, ADMINISTRATION 146697 0 7875 0 0 0 23386 0 19926 0 197884 0 0 0 DR ROBERT L COLEMAN MD DIRECTOR-AT-LARGE 199875 CONSULTING SERVICES 0 DR LARRY J COPELAND MD PRESIDENT 166400 CONSULTING SERVICES 0 FORM 990, PART VI, SECTION A, LINE 4 THE BYLAWS WERE UPDATED IN THE FOLLOWING WAYS: -ADDITIONAL OFFICER POSITIONS WERE CREATED. THE OFFICERS OF THE CORPORATION SHALL BE A LEGACY GROUP (GOG/NRG) CHAIRPERSON, A PRESIDENT, A SENIOR VICE PRESIDENT, VICE PRESIDENT(S), SECRETARY, A TREASURER, A PRESIDENT-ELECT (FROM TIME TO TIME), A LEGACY GROUP (GOG/NRG) CHAIRPERSON -ELECT (FROM TIME TO TIME), AND SUCH OTHER OFFICERS AS THE BOARD MAY DESIGNATE. -ADDITIONAL EX-OFFICIO VOTING DIRECTOR POSITIONS WERE CREATED. -THE NUMBER OF AT LARGE DIRECTORS WAS CHANGED TO BETWEEN 4 AND 10. -NOMINATION AND ELECTION PROCEDURES WERE UPDATED. -VARIOUS UPDATES TO TERM LIMITS WERE IMPLEMENTED. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 IS REVIEWED BY THE CFO BEFORE FILING. FORM 990, PART VI, SECTION B, LINE 12C CONFLICT OF INTEREST DISCLOSURE FORMS ARE REVIEWED ANNUALLY BY THE FOUNDATION CHAIR, AND ON AN INTERIM BASIS. THE FOUNDATION CHAIR REVIEWS ANNUAL FORMS NO LATER THAN NOVEMBER 1 OF EACH YEAR, AND INTERIM FORMS WITHIN 30 DAYS. THE CONFLICT IS MANAGED, REDUCED, OR ELIMINATED, AT LEAST ON AN INTERIM BASIS, WITHIN 60 DAYS OF ITS IDENTIFICATION. FORM 990, PART VI, SECTION B, LINE 15 OFFICER AND KEY EMPLOYEE SALARY IS APPROVED BY THE CEO AND TREASURER ANNUALLY, IN CONSULTATION WITH A COMPENSATION SURVEY WHICH IS OBTAINED PERIODICALLY. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, POLICIES, AND FINANCIAL STATEMENTS ARE MADE AVAILABLE AT RECEPTIONIST'S DESK. FORM 990, PART VII, SECTION A: DR. MANNEL'S EMPLOYER, THE UNIVERSITY OF OKLAHOMA, WAS COMPENSATED $33,333 FOR DR. MANNEL'S SERVICES TO THE BOARD.